tirzepatide approval for weight loss Lilly Rises on FDA of Weight-Loss Drug Zepbound Sleep Apnea Breaking News: FDA Approves Tirzepatide

Obesity is the most common chronic health condition globally, affecting around 650 million adults

While Ozempic can help some people lose weight, it can also cause side effects ranging from mild to serious

Medicinal herbs in the relief of neurological, cardiovascular, and respiratory symptoms after COVID-19 infection a literature review

The acylation modification gives retatrutide a half-life of approximately six days, allowing once-weekly dosing, but that long half-life also means dosing errors compound over time rather than resolving quickly

If you are taking semaglutide and think you might have a kidney infection, it is important to act quickly